Evaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid Model

Clinical trial NCT05136014 · UNKNOWN

Trial details

NCT number: NCT05136014
Sponsor: Central Hospital, Nancy, France
Status: UNKNOWN
Study type: OBSERVATIONAL

Lung Cancer Lung Adenocarcinoma EGFR Activating Mutation KRAS Mutation-Related Tumors Non Small Cell Lung Cancer

Start date: 2021-11-01
Primary completion: 2021-11-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.